Reviewing Cue Health (NASDAQ:HLTH) and Codex DNA (NASDAQ:DNAY)

Cue Health (NASDAQ:HLTHGet Rating) and Codex DNA (NASDAQ:DNAYGet Rating) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, earnings, profitability, dividends, analyst recommendations, risk and institutional ownership.

Earnings and Valuation

This table compares Cue Health and Codex DNA’s gross revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Cue Health $618.11 million 1.22 $86.42 million N/A N/A
Codex DNA $11.04 million 11.10 -$38.96 million ($2.28) -1.83

Cue Health has higher revenue and earnings than Codex DNA.

Insider and Institutional Ownership

26.4% of Cue Health shares are owned by institutional investors. Comparatively, 87.6% of Codex DNA shares are owned by institutional investors. 7.0% of Cue Health shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Profitability

This table compares Cue Health and Codex DNA’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Cue Health N/A N/A N/A
Codex DNA -311.52% -46.56% -36.63%

Analyst Ratings

This is a breakdown of current recommendations for Cue Health and Codex DNA, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cue Health 0 0 0 0 N/A
Codex DNA 0 0 3 0 3.00

Codex DNA has a consensus target price of $15.86, indicating a potential upside of 280.26%. Given Codex DNA’s higher probable upside, analysts clearly believe Codex DNA is more favorable than Cue Health.

Summary

Cue Health beats Codex DNA on 6 of the 10 factors compared between the two stocks.

About Cue Health (Get Rating)

Cue Health Inc., a healthcare technology company, designs and develops diagnostic platform for diagnostic tests for individuals, enterprises, healthcare providers and payors, and public health agencies. The company offers Cue Integrated Care platform comprising hardware and software components, such as Cue Health Monitoring System consisting of Cue Reader, a portable and reusable reader, Cue Cartridge, a single-use test cartridge, and Cue Wand, a sample collection wand; Cue Data and Innovation Layer, a solution with cloud-based data and analytics capability; Cue Virtual Care Delivery Apps, which include Cue Health App and Cue Enterprise Dashboard; and Cue Ecosystem Integrations and Apps, a solution that allows integrations with third-party applications and sensors. It also provides COVID-19 testing kits for the Cue Health Monitoring System The company was formerly known as Cue Inc and changed its name to Cue Health Inc. in December 2017. Cue Health Inc. was incorporated in 2010 and is headquartered in San Diego, California.

About Codex DNA (Get Rating)

Codex DNA, Inc., a synthetic biology company, manufactures and sells synthetic biology instruments, reagents, and associated products and related services, primarily to pharmaceutical and academic laboratories worldwide. Its solutions include BioXp system that empowers researchers to go from a digital DNA sequence to endpoint-ready synthetic DNA; BioXp portal, an online portal that offers an intuitive guided workflow and design tools for building new DNA sequences and assembling them into vectors of choice; BioXp kits that contain building blocks and reagents, including its Gibson Assembly branded reagents, for specific synthetic biology workflow applications; Cloud-based scripts; Benchtop reagents that contain all the reagents necessary to proceed with a specific synthetic biology workflow on the benchtop using products generated on the BioXp system; Biofoundry Services, which enable a customer to order and receive the BioXp system endpoint-ready products, such as genes, clones, cell-free amplified DNA, and variant libraries; and short oligo ligation assembly enzymatic DNA synthesis. It also serves government institutions, contract research organizations, and synthetic biology companies. The company was formerly known as SGI-DNA, Inc. and changed its name to Codex DNA, Inc. in March 2020. Codex DNA, Inc. was incorporated in 2011 and is headquartered in San Diego, California.

Receive News & Ratings for Cue Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cue Health and related companies with MarketBeat.com's FREE daily email newsletter.